Lifecore Biomedical Inc. (LFCR)
Healthcare
Drug Manufacturers - Specialty & Generic
4.40 $
+1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Lifecore Biomedical Inc. (LFCR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.8% of the shares are freely tradable; institutional investors hold 77.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
77.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
51.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
38Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Wynnefield Capital Inc | 12.54 | 4,703,216 | +0.0 | 03/31/2026 |
| Legion Partners Asset Management, LLC | 11.90 | 4,461,823 | +0.0 | 03/31/2026 |
| Greenhaven Road Investment Management, L.P. | 9.43 | 3,537,573 | -3.9 | 03/31/2026 |
| 325 Capital LLC | 5.77 | 2,162,466 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.00 | 1,877,305 | -1.6 | 03/31/2026 |
| Vanguard Group Inc | 4.46 | 1,673,666 | +3.1 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.44 | 1,290,136 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.17 | 815,107 | +4.5 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 2.04 | 764,734 | +1.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.19 | 822,113 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.